Skip to main content

Veracyte Atlas DHF 011-003 Evaluation of a biomarker test for the early molecular profiling of lung cancer utilizing cytological samples

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

Veracyte, Inc.

Start Date

April 23, 2021

End Date

March 31, 2024
 

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

Veracyte, Inc.

Start Date

April 23, 2021

End Date

March 31, 2024